Anaptysbio (ANAB) Tax Provisions (2018 - 2026)

Anaptysbio (ANAB) posted Tax Provisions of $40000.0 for Q1 2026, up 107.52% on a QoQ basis from -$532000.0 in Q4 2025, and down 9.09% year-over-year from $44000.0 in Q1 2025.

Anaptysbio (ANAB) Tax Provisions (2018 - 2026) Analysis & Trends

Anaptysbio's Tax Provisions history runs 6 years deep, the most recent figure standing at $40000.0 for Q1 2026.

  • Quarterly Tax Provisions fell 9.09% year-over-year to $40000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$453000.0 (up 98.51% YoY) and the FY2025 annual result came in at -$449000.0, up 98.53% from the prior year.
  • Tax Provisions was $40000.0 for Q1 2026 at Anaptysbio, up from -$532000.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $44000.0 in Q1 2025 and bottomed at -$30.5 million in Q4 2024.
  • A 4-year average of -$4.4 million and a median of $9000.0 in 2024 frame the typical range for Tax Provisions.
  • Annual changes were most pronounced in 2024 — Tax Provisions tumbled 762575.0% — and 2025, when it jumped 333.33%.
  • Anaptysbio's Tax Provisions stood at -$4000.0 in 2023, then tumbled by 762575.0% to -$30.5 million in 2024, then jumped by 98.26% to -$532000.0 in 2025, then jumped by 107.52% to $40000.0 in 2026.
  • Business Quant data shows ANAB's Tax Provisions at $40000.0 in Q1 2026, -$532000.0 in Q4 2025, and $39000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 125,146.46
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -859,000.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 31.86 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 221.50 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 104.00 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -60.00 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Anaptysbio 1.55 Bn 1.27 Bn - 40,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 40,000.00
Dec 31, 2025 -532,000.00
Jun 30, 2025 39,000.00
Mar 31, 2025 44,000.00
Dec 31, 2024 -30.51 Mn
Jun 30, 2024 9,000.00
Dec 31, 2023 -4,000.00
Dec 31, 2019 -22,000.00
Sep 30, 2019 -51,000.00
Jun 30, 2019 -60,000.00
Mar 31, 2019 -19,000.00
Dec 31, 2018 -192,000.00